Georgia A McCann
UT Badge
Accepting new patients

McCann, MD

  • Gynecologic Oncology
Call: 210-450-9500

If you're an existing patient of Dr. McCann, please connect via MyChart

About me

About Me

Dr. Georgia McCann joined the faculty of UT Health San Antonio in July 2013 as an assistant clinical professor in the division of gynecologic oncology. Her expertise includes the diagnosis, treatmentand research of cervical, endometrial, ovarian, and vulvar cancers. Dr. McCann also has advanced surgical training in robotic and laparoscopic procedures, radical pelvic and reconstructive surgery, surgery for the diagnosis and treatment of gynecologic cancersand complicated benign gynecologic conditions. She completed her gynecologic oncology fellowship at The Ohio State University Medical Center after a residency in obstetrics and gynecology at the Hospital of the University of Pennsylvania, where she was elected administrative chief resident. Dr. McCann has authored or co-authored more than 35 papers published in peer reviewed journals and looks forward to advancing her research while caring for the unique patient population of central and south Texas.
San Antonios Top Doctors for Women
Backes FJ, Rosen M, Liang M, McCann GA, Clements A, Cohn DE, OMalley DM, Salani R, Fowler JM. Robotic Hysterectomy for Endometrial Cancer in Obese Patients With Comorbidities: Evaluating Postoperative Complications. Int J Gynecol Cancer. 2015 Sep;25(7):1271-6. doi: 0.1097/IGC.0000000000000480. PubMed PMID: 26017249.
McCann GA, Naidu S, Rath KS, Bid HK, Tierney BJ, Suarez A, Varadharaj S, Zhang J, Hideg K, Houghton P, Kuppusamy P, Cohn DE, Selvendiran K. Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor. Oncoscience. 2014 Mar 31;1(3):216-28. eCollection 2014. PubMed PMID: 25594014; PubMed Central PMCID: PMC4278289.
McCann GA, Cohn DE, Jewell EL, Havrilesky LJ. Lymphatic mapping and sentinellymph node dissection compared to complete lymphadenectomy in the management ofearly-stage vulvar cancer: A cost-utility analysis. Gynecol Oncol. 2015Feb;136(2):300-4. doi: 10.1016/j.ygyno.2014.11.079. Epub 2014 Dec 2. PubMed PMID:25478927.






  • Award
  • Award
  • Award
  • Award
  • Award



Medical School:
Thomas Jefferson Medical College

University of Pennsylvania Medical Center

Ohio State University Medical Center


Board Certification:
American Board of OBG/Gynecologic Oncology
American Board of Obstetrics & Gynecology

Treatment and care

Treatment and Care

Specific areas of interest and expertise include:

  • Abnormal Pap Smear
  • Atypical Hyperplasia
  • Cervical Cancer
  • Endometrial Cancer
  • Endometrial Hyperplasia
  • Fallopian Tube Cancer
  • Female Germ Cell Tumor
  • Fibroid Tumor
  • Gynecologic Cancer
  • Leiomyosarcoma Of The Uterus
  • Ovarian Cancer
  • Ovarian Tumor
  • Pelvic Mass
  • Peritoneal Cancer
  • Squamous Cell Cancer
  • Trophoblastic Disease
  • Tumor Of Uterine Muscle
  • Uterine Cancer
  • Uterine Sarcoma
  • Vaginal Cancer
  • Vulvar Cancer
  • Vulvar Disease